Ophthalmology. Retina۲۰۲۵مطالعه مشاهده ای۲ استنادنمایه شده در PubMed
Kyle S Chan, Harrshavasan T S Congivaram, Andrea S Cuamatzi-Castelan, Jeremy A Lavine, SOURCE Consortium
چکیده
There is a need for therapies that delay neovascular age-related macular degeneration (AMD) progression. Levodopa (L-DOPA) and dopamine receptor D2 (DRD2) agonists have been proposed as potential agents. We investigated the association between dopamine agonist (DA) exposure and conversion to…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1016/j.oret.2025.12.004